Fortis Healthcare is currently trading at Rs 112.40, up by 0.10 points or 0.09% from its previous closing of Rs 112.30 on the BSE.
The scrip opened at Rs 111.10 and has touched a high and low of Rs 113.35 and Rs 109.30 respectively. So far 40156 shares were traded on the counter.
The BSE group 'A' stock of face value Rs 10 has touched a 52 week high of Rs 171.50 on 27-Jul-2011 and a 52 week low of Rs 110.05 on 22-Nov-2011.
Last one week high and low of the scrip stood at Rs 116.45 and Rs 109.30 respectively. The current market cap of the company is Rs 4550.14 crore.
The promoters holding in the company stood at 81.49% while Institutions and Non-Institutions held 9.29% and 9.23% respectively.
Fortis Healthcare (India) has launched a chain of stand-alone dialysis centres -RENKARE. These stand-alone centres will expand Fortis’ reach and help meet the rising demand for quality dialysis. Further, the company plans to set up 50 standalone dialysis centres across the country over the next two years, in a phased manner. In the first phase, six centres will come up across Delhi and NCR covering the territory in the North, South, West and East.
RENKARE is manned by a team of experienced renal specialists and is equipped with state-of the- art equipment and technology, will offer excellence in dialysis through reliable, safe and effective services in a hygienic and home-like environment. The centres will also focus on educational programmes, to help patients live healthy and productive lives, even while on haemodialysis.
The centres will have standardised, international dialysis protocols, including the unique Water Testing Protocol, combined with a clean environment and other comforts like reclining chairs, WiFi connectivity and personal LCD screens for a relaxed dialysis experience.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 6743.65 |
| Max Healthcare Inst | 989.65 |
| Narayana Hrudayalay | 1259.00 |
| Aster DM Healthcare | 426.55 |
| Global Health | 1072.45 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Claim your FREE 15-day access to the most practical investing handbook.
Hurry, limited to the first 10 users today!
FREE Become a savvy and confident
stock investor.
Hurry, limited to the first 10 users today!
Download APP
